SCHEMBL480272

SCHEMBL480272

COC(=O)c1ccc(C(c2ccc(OCc3ccccn3)cc2)C(C)(C)C)nc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 1/20 0.49
ALOX5AP P20292 1/20 0.43
VNN1 O95497 1/20 0.42
ADAMTS4 O75173 1/20 0.42
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HDAC9 Q9UKV0 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
MAPK14 Q16539 4/20 0.41
SMO Q99835 4/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
KDM4E B2RXH2 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12356701 0.90 PARP10 (0.55) PARP10ALOX5APADAMTS4MAPK14SMO
SCHEMBL2250280 0.90 PARP10 (0.55) PARP10ALOX5APADAMTS4MAPK14SMO
SCHEMBL13248357 0.82 PARP10 (0.51) PARP10ADAMTS4MAPK14SMOMEN1
SCHEMBL2251349 0.81 PARP10 (0.57) PARP10ADAMTS4MAPK14SMOKDM4E
SCHEMBL2992851 0.81 PARP10 (0.57) PARP10ADAMTS4KDM4EALDH1A1SMN1; SMN2
SCHEMBL2986740 0.80 PARP10 (0.57) PARP10ADAMTS4MAPK14SMOMEN1
SCHEMBL1732629 0.80 PARP10 (0.69) PARP10MAPK14SMOMEN1KMT2A
SCHEMBL30320388 0.80 PARP10 (0.69) PARP10MAPK14SMOMEN1KMT2A
SCHEMBL2253252 0.80 PARP10 (0.74) PARP10ADAMTS4MAPK14SMOKDM4E
SCHEMBL2795215 0.79 CYP11B1 (0.43) PARP10ALOX5APKDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8440672-B2 Diphenyl substituted alkanes MERCK SHARP & DOHME CORP. (US) 2013-05-14 US disclosed
EP-2064204-B1 INHIBITORS OF 5 -LIPOXYGENASE ACTIVATING PROTEIN ( FLAP) MERCK SHARP & DOHME (US) 2012-02-01 EP disclosed
US-20100168076-A1 DIPHENYL SUBSTITUTED ALKANES MERCK SHARP & DOHME CORP. 2010-07-01 US disclosed
EP-2064204-A1 INHIBITORS OF 5 -LIPOXYGENASE ACTIVATING PROTEIN ( FLAP) Merck & Co., Inc. (US) 2009-06-03 EP disclosed
WO-2008030369-A1 INHIBITORS OF 5 -LIPOXYGENASE ACTIVATING PROTEIN ( FLAP) MERCK & CO., INC. (US) 2008-03-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100168076-A1 DIPHENYL SUBSTITUTED ALKANES ALOX5, ALOX15, ALOX15B PARP10 988/4885ALOX5AP 14/4885VNN1 2699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.